What is the Projected CAGR value of the Dravet Syndrome Therapeutics Market ?
Dravet Syndrome Therapeutics Market is expected to grow at a CAGR of 11.5% during the forecast period 2024-2031.
Who are the key players in Dravet Syndrome Therapeutics Market ?
Major players are Epygenix Therapeutics, Inc., GW Pharmaceuticals Plc., Ovid Therapeutics, Takeda Pharmaceutical Company Ltd, OPKO Health Inc., Zogenix, Inc, Biocodex S.A., PTC Therapeutics, Inc., and Biscayne Neurotherapeutics, Inc.